Cell-free expression of the outer membrane protein OprF of Pseudomonas aeruginosa for vaccine purposes

Life Sci Alliance. 2021 May 10;4(6):e202000958. doi: 10.26508/lsa.202000958. Print 2021 Jun.

Abstract

Pseudomonas aeruginosa is the second-leading cause of nosocomial infections and pneumonia in hospitals. Because of its extraordinary capacity for developing resistance to antibiotics, treating infections by Pseudomonas is becoming a challenge, lengthening hospital stays, and increasing medical costs and mortality. The outer membrane protein OprF is a well-conserved and immunogenic porin playing an important role in quorum sensing and in biofilm formation. Here, we used a bacterial cell-free expression system to reconstitute OprF under its native forms in liposomes and we demonstrated that the resulting OprF proteoliposomes can be used as a fully functional recombinant vaccine against P. aeruginosa Remarkably, we showed that our system promotes the folding of OprF into its active open oligomerized state as well as the formation of mega-pores. Our approach thus represents an easy and efficient way for producing bacterial membrane antigens exposing native epitopes for vaccine purposes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Outer Membrane Proteins / genetics
  • Bacterial Outer Membrane Proteins / immunology
  • Bacterial Outer Membrane Proteins / metabolism
  • Bacterial Proteins / genetics
  • Bacterial Proteins / immunology*
  • Bacterial Proteins / metabolism
  • Epitopes / immunology
  • Gene Expression / genetics
  • Liposomes / pharmacology
  • Protein Engineering / methods*
  • Pseudomonas aeruginosa / immunology*
  • Pseudomonas aeruginosa / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Vaccines / immunology

Substances

  • Bacterial Outer Membrane Proteins
  • Bacterial Proteins
  • Epitopes
  • Liposomes
  • OprF protein, Pseudomonas aeruginosa
  • Recombinant Fusion Proteins
  • Vaccines